Ozempic-class drugs linked to serious gastrointestinal risks, study suggests

Weight-loss drugs in the same class as Wegovy and Ozempic may carry a rare but increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, according to a study published on Thursday.

#News #CBCNews #ozempic

Watch The National live on YouTube Sunday-Friday at 9 p.m. ET

Subscribe to The National:
https://www.youtube.com/user/CBCTheNa...

More from CBC News | https://www.cbc.ca/news

The National is the flagship of CBC News, showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault and Ian Hanomansing, our team of trusted reporters helps you make sense of the world, wherever you are.

• #news_politics
• #ozempic
• #weight_loss
• #weight_loss_drugs
• #gastrointestinal_issues
• #gastrointestinal_problems
• #pancreatitis
• #intestinal_blockage
• #stomach_paralysis
• #obesity_drugs
• #diabetes_drug
• #ubc
• #university_of_british_columbia
• #serious_medical_condition
• #side_effect
• #ozempic_side_effects
• #wegovy
• #contravene_bupropion_naltrexone_pills
• #rybelsus
• #abdominal_pain
• #cbc_news
• #cbc
• #the_national
• #christine_birak